Construction and Analysis of lncRNA-Mediated ceRNA Network in Cervical Squamous Cell Carcinoma by Weighted Gene Co-Expression Network Analysis.


Journal

Medical science monitor : international medical journal of experimental and clinical research
ISSN: 1643-3750
Titre abrégé: Med Sci Monit
Pays: United States
ID NLM: 9609063

Informations de publication

Date de publication:
09 Apr 2019
Historique:
entrez: 10 4 2019
pubmed: 10 4 2019
medline: 3 8 2019
Statut: epublish

Résumé

BACKGROUND More and more recent studies have clearly shown that long non-coding RNA (lncRNA) should be considered as a fundamental part of the ceRNA network, mainly because lncRNA can act as miRNA sponges to regulate the protein-coding gene expression. Nevertheless, it is still not clear how lncRNA-mediated ceRNAs function in cervical squamous cell carcinoma (CESC). Moreover, information about the ceRNA regulatory mechanism is also remarkably limited; thus, prediction of CESC prognosis using ceRNA-related information remains challenging. MATERIAL AND METHODS We collected 306 RNA (lncRNA, miRNA, and mRNA) expression profile datasets obtained from cervical squamous cancer tissues plus 3 more from adjacent cervical tissues via the TCGA database. Subsequently, we constructed a lncRNAs-miRNAs-mRNAs CESC ceRNA network, and Gene Ontology (GO) analysis was carried out. RESULTS We identified a total of 30 DElncRNAs, 70 DEmiRNAs, and 1089 DEmRNAs in CESC. Subsequently, to reveal the expression patterns of dysregulated genes, weighted gene co-expression network analysis was carried out, resulting in 3 co-expression modules with significantly related clinical properties. The constructed aberrant lncRNAs-miRNAs-mRNAs CESC ceRNA network was composed of 17 DEmiRNAs, 5 DElncRNAs, and 7 DEmRNAs. Moreover, the survival analysis was performed for DElncRNAs, DEmiRNAs, and DEmRNAs. CONCLUSIONS The present study shows the involvement of the lncRNA-related ceRNA network in the pathogenesis of CESC. We believe the newly generated ceRNA network will provide more insights into the lncRNA-mediated ceRNA regulatory mechanisms.

Identifiants

pubmed: 30965350
pii: 913471
doi: 10.12659/MSM.913471
pmc: PMC6474298
doi:

Substances chimiques

MicroRNAs 0
RNA, Long Noncoding 0
RNA, Messenger 0
RNA, Neoplasm 0

Types de publication

Journal Article

Langues

eng

Pagination

2609-2622

Références

Nature. 2001 Feb 15;409(6822):814-6
pubmed: 11236992
ORL J Otorhinolaryngol Relat Spec. 2001 Jul-Aug;63(4):229-32
pubmed: 11408819
BMC Bioinformatics. 2008 Dec 29;9:559
pubmed: 19114008
Virology. 2009 Feb 20;384(2):260-5
pubmed: 19135222
ScientificWorldJournal. 2010 Jan 08;10:90-102
pubmed: 20062956
Genome Biol. 2011;12(2):R16
pubmed: 21324177
BMC Cancer. 2011 Feb 22;11:80
pubmed: 21338529
Gynecol Oncol. 2011 Oct;123(1):157-63
pubmed: 21742370
Cell. 2011 Aug 5;146(3):353-8
pubmed: 21802130
Asian Pac J Cancer Prev. 2013;14(9):5101-5
pubmed: 24175783
Nature. 2014 Feb 20;506(7488):371-5
pubmed: 24390348
Tumour Biol. 2014 Dec;35(12):11913-20
pubmed: 25142231
Contemp Oncol (Pozn). 2015;19(1A):A68-77
pubmed: 25691825
Tumour Biol. 2015 May;36(5):3129-36
pubmed: 25809705
J Med Genet. 2015 Oct;52(10):710-8
pubmed: 26358722
J Renin Angiotensin Aldosterone Syst. 2016 Jul-Sep;17(3):1470320316663327
pubmed: 28304186
Am J Transl Res. 2017 May 15;9(5):2327-2339
pubmed: 28559983
Clin Oral Investig. 2018 Jan;22(1):401-409
pubmed: 28616749
Tumour Biol. 2017 Jun;39(6):1010428317701308
pubmed: 28651495
Tumour Biol. 2017 Jul;39(7):1010428317711315
pubmed: 28671039
Sci Rep. 2017 Nov 16;7(1):15683
pubmed: 29146991
Oncotarget. 2017 Nov 30;8(66):110552-110565
pubmed: 29299168
Oncogenesis. 2018 Jan 23;7(1):4
pubmed: 29358619
Clin Chim Acta. 2018 Jun;481:99-107
pubmed: 29501692
Theranostics. 2018 Feb 12;8(7):1850-1868
pubmed: 29556360
Oncol Lett. 2018 May;15(5):6115-6122
pubmed: 29616093
Int J Biol Markers. 2018 Apr 1;:1724600818768459
pubmed: 29690802
Biomed Pharmacother. 2018 Mar;99:638-644
pubmed: 29710461
Cancer. 1993 Oct 15;72(8):2389-93
pubmed: 8402454

Auteurs

Weihao Chen (W)

College of Traditional Chinese Medicine, Jinan University, Guangzhou, Guangdong, China (mainland).

Xudong Chen (X)

College of Traditional Chinese Medicine, Jinan University, Guangzhou, Guangdong, China (mainland).

Yurong Wang (Y)

College of Traditional Chinese Medicine, Jinan University, Guangzhou, Guangdong, China (mainland).

Tianhao Liu (T)

College of Traditional Chinese Medicine, Jinan University, Guangzhou, Guangdong, China (mainland).

Yudan Liang (Y)

College of Traditional Chinese Medicine, Jinan University, Guangzhou, Guangdong, China (mainland).
Jiangmen Wuyi Traditional Chinese Medicine Hospital, Jiangmen, Guangdong, China (mainland).

Ya Xiao (Y)

College of Traditional Chinese Medicine, Jinan University, Guangzhou, Guangdong, China (mainland).

Liguo Chen (L)

College of Traditional Chinese Medicine, Jinan University, Guangzhou, Guangdong, China (mainland).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH